Skin care [Dr. Wu Skincare FY2026 Q2 Earnings Call] Taiwan's Dr. Wu first-half EPS nearly halved to NT$2.20, revenue down 16%; CFO admits second-half profit will remain challenging – finance.biggo.com September 15, 2026 jhgreene [Dr. Wu Skincare FY2026 Q2 Earnings Call] Taiwan’s Dr. Wu first-half EPS nearly halved to NT$2.20, revenue down 16%; CFO admits second-half profit will remain challenging finance.biggo.com